Last update 07 Jun 2025

Yttrium-90 (90Y) DOTATATE

Overview

Basic Info

Drug Type
Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals
Synonyms
DOTA-0-Tyr3-Octreotate
Target
Action
modulators
Mechanism
SSTR modulators(Somatostatin receptor modulators)
Active Indication-
Originator Organization-
Active Organization-
Inactive Organization
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
Boost your research with our ADC technology data.

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Carcinoid TumorPhase 2
Poland
02 Nov 2004
Gastro-Enteropancreatic Neuroendocrine TumorPhase 2
Poland
02 Nov 2004
PheochromocytomaPhase 2
Poland
02 Nov 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
Y 90 -Dotatate therapy
peqacdntkc(erodmdqegu) = TMA has been described in association with Y 90 -Dotatate therapy and this case demonstrates this rare complication which carries a poor renal prognosis hrezrgkezp (qnlmnscrmj )
Negative
05 Nov 2019
Y-Dotatate
(Plasma exchange)
Not Applicable
-
19
Chemotherapy
nhgurzpsgj(wbrkhvevsy) = In one patient the value of Hb was assessed as toxicity grade 3 fcxqwssxvh (kmxhdktdvc )
Positive
10 Oct 2010
Not Applicable
89
kjbhewegod(rvfzalkitw) = nmjhrdkytx gekbkqazfy (pgwnuyqevx )
Positive
20 May 2009
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free